Toby Ferguson
CIK: 0002015616
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Voyager Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 6, 2026VYGR
Voyager Therapeutics, Inc.
Award(A)Direct45K shares- - Aug 18, 2025VYGR
Voyager Therapeutics, Inc.
Sale(S)Direct19K shares at avg. $3.73$71K - Apr 2, 2025VYGR
Voyager Therapeutics, Inc.
Sale(S)Direct10.1K shares at avg. $3.43$35K - Feb 21, 2025VYGR
Voyager Therapeutics, Inc.
Award(A)Direct63K shares-
1-4 of 4 transactions
About Ferguson Toby
Ferguson Toby (SEC CIK 0002015616) files insider reports with the SEC as Chief Medical Officer of Voyager Therapeutics, Inc. (VYGR).
Signal8 holds 4 ownership filings by Ferguson Toby, all Form 4s, filed between Feb 24, 2025 and Feb 10, 2026. Those filings report 4 transactions, from Feb 21, 2025 to Feb 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ferguson Toby's filings is in LEXINGTON, MA.
Recent filings by Ferguson Toby
Other insiders filing for Voyager Therapeutics, Inc. (VYGR)
- SCANGOS GEORGE A, Director
- MACKEY CATHERINE J, Director
- Hyman Steven, Director
- Vitale Nancy, Director
- Higgins Michael J, Director
- Onyia Jude, Director